IP Library Assignment 019628/0144
Patent Assignment
Reel/Frame 019628/0144

Merger

Recorded: 2007-08-01 Pages: 22
Assignor
ADVISYS INC.
Executed: 2007-02-21
Assignee
VGX PHARMACEUTICALS, INC.
450 SENTRY PARKWAY, BLUE BELL, PENNSYLVANIA, 19422
Covered Properties (16)
Treating Anemia in Subjects by Administration of Plasmids Encoding Growth Hormone Releasing Hormone
Patent: 7,241,744 →
Application: 10/315,907 →
Publication: US 2004/0057941
Electrode Assembly for Constant-Current Electroporation and Use
Patent: 7,245,963 →
Application: 10/360,768 →
Publication: US 2004/0167458
Codon Optimized Synthetic Plasmids
Patent: 7,316,925 →
Application: 10/619,939 →
Publication: US 2004/0092009
Constant Current Electroporation Device and Methods of Use
Patent: 8,209,006 →
Application: 10/657,725 →
Publication: US 2005/0052630
Synthetic muscle promoters with activities exceeding naturally occurring regulatory sequences in cardiac cells
Application: 10/699,597 →
Publication: US 2004/0175727
Reducing culling in herd animals growth hormone releasing hormone (GHRH)
Application: 10/764,818 →
Publication: US 2004/0204358
Insulin-like growth factor (IGF-I) plasmid-mediated supplementation for therapeutic applications
Patent: 8,481,504 →
Application: 10/798,896 →
Publication: US 2005/0238624
Plasmid mediated GHRH supplementation for renal failures
Application: 10/827,918 →
Publication: US 2005/0004060
Devices and Methods for Biomaterial Production
Patent: 7,238,522 →
Application: 10/857,439 →
Publication: US 2005/0014245
Canine Specific Growth Hormone Releasing Hormone
Patent: 7,361,642 →
Application: 10/894,644 →
Publication: US 2005/0032737
Reducing Arthritis and Lameness in Subjects by Growth Hormone Releasing Hormone (Ghrh) Supplementation
Patent: 8,188,056 →
Application: 11/015,935 →
Publication: US 2005/0182014
Enhanced Secretion / Retention of Growth Hormone Releasing Hormone (Ghrh) from Muscle Cells by Species-Specific Signal Peptide
Patent: 7,517,863 →
Application: 11/034,682 →
Publication: US 2005/0171046
Growth hormone releasing hormone enhances vaccination response
Application: 11/186,282 →
Publication: US 2006/0025368
Optimized High Yield Synthetic Plasmids
Patent: 7,846,720 →
Application: 11/339,894 →
Publication: US 2006/0188988
Electrode Assembly for Constant-Current Electroporation and Use
Patent: 7,664,545 →
Application: 11/495,021 →
Publication: US 2006/0264807
Intradermic and subcutaneous micro-electroporation device and methods of use for therapeutic or prophilactic vaccination
Application: 60/852,149 →
Related Assignments (6)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Apr 24, 2009
From: ADVISYS INC.
To: VGX PHARMACEUTICALS, INC.
Reel/Frame 022592/0787 →
Assignment of Assignor's Interest Apr 24, 2009
From: DRAGHIA-AKLI, RUXANDRA; CARPENTER, ROBERT H.; KERN, DOUGLAS R.; WILKINSON, WILLIAM R.
To: ADVISYS, INC.
Reel/Frame 022601/0099 →
Assignment of Assignor's Interest Mar 8, 2011
From: VGX PHARMACEUTICAL, INC.
To: VGXI, INC.
Reel/Frame 025918/0910 →
Confirmatory License Oct 2, 2014
From: BAYLOR COLLEGE OF MEDICINE
To: NATIONAL INSTITUTES OF HEALTH (NIH), U.S. DEPT. OF HEALTH AND HUMAN SERVICES (DHHS), U.S. GOVERNMENT
Reel/Frame 033886/0433 →
Merger and Change of Name Dec 21, 2020
From: VGX PHARMACEUTICALS, INC.; INOVIO ACQUISITION, LLC
To: VGX PHARMACEUTICALS, LLC
Reel/Frame 054704/0830 →
Merger Feb 2, 2021
From: VGX PHARMACEUTICALS, LLC
To: INOVIO PHARMACEUTICALS, INC.
Reel/Frame 055114/0843 →